Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Oral Oncology|February 21, 2006
Oxaliplatin, folinic acid and 5-fluorouracil (OFF) in patients with recurrent advanced head and neck cancer: a phase II feasibility studyJan Dirk Raguse, Hans Joachim Gath, Helmut Oettle, et al.
Onkologie|May 1, 2010
[New data on pancreatic cancer]Rainer Fietkau, Volker Heinemann, Helmut Oettle, et al.
Oral Oncology|December 25, 2003
Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumourJan-Dirk Raguse, Hans Joachim Gath, Jürgen Bier, et al.
Onkologie|March 20, 2009
Second-line therapy in refractory pancreatic cancer. results of a phase II studyUwe Pelzer, Jens Stieler, Lars Roll, et al.
Medical Microbiology and Immunology|May 15, 2002
Quantitation of the spliced late gene of human cytomegalovirus and its kinetics during experimental infectionJoachim Hänfler, Karl-Anton Kreuzer, Katja Laurisch, et al.
BMC Cancer|March 11, 2010
Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II studyUwe Pelzer, Dirk Arnold, Mehmet Gövercin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2011
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study groupUwe Pelzer, Ingo Schwaner, Jens Stieler, et al.
Medical Microbiology and Immunology|November 15, 2003
Quantitation of cytomegalovirus (hCMV) DNA and beta-actin DNA by duplex real-time fluorescence PCR in solid organ (liver) transplant recipientsJoachim Hänfler, Karl Anton Kreuzer, Katja Laurisch, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 28, 2005
Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRIJuri Ruf, Enrique Lopez Hänninen, Helmut Oettle, et al.
Oncology Research and Treatment|November 25, 2015
Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus GemcitabineArndt Vogel, Frank Kullmann, Volker Kunzmann, et al.
Pageof 5